Education
About Us
Working with TipRanks
Follow Us
Invion Ltd. (AU:IVX)
OTHER OTC:IVX
IVX Stock Chart & Stats
AU$0.08
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.08
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.30
Previous CloseN/A
Volume36.17K
Average Volume (3M)89.29K
Market Cap
AU$8.05M
Enterprise ValueAU$7.22M
Total Cash (Recent Filing)AU$850.37K
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding85,647,255
10 Day Avg. Volume192,721
30 Day Avg. Volume89,292
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.96
Price to Sales (P/S)0.00
P/FCF Ratio-2.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Invion News
IVX FAQ
What was Invion Ltd.’s price range in the past 12 months?
Invion Ltd. lowest share price was AU$0.07 and its highest was AU$0.29 in the past 12 months.
What is Invion Ltd.’s market cap?
Invion Ltd.’s market cap is AU$8.05M.
When is Invion Ltd.’s upcoming earnings report date?
Invion Ltd.’s upcoming earnings report date is Mar 04, 2026 which is in 75 days.
How were Invion Ltd.’s earnings last quarter?
Invion Ltd. released its earnings results on Aug 27, 2025. The company reported -AU$0.094 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.094.
Is Invion Ltd. overvalued?
According to Wall Street analysts Invion Ltd.’s price is currently Overvalued.
Does Invion Ltd. pay dividends?
Invion Ltd. does not currently pay dividends.
What is Invion Ltd.’s EPS estimate?
Invion Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion Ltd. have?
Invion Ltd. has 85,647,255 shares outstanding.
What happened to Invion Ltd.’s price movement after its last earnings report?
Invion Ltd. reported an EPS of -AU$0.094 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.043%.
Which hedge fund is a major shareholder of Invion Ltd.?
Currently, no hedge funds are holding shares in AU:IVX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Invion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.00%
12-Months-Change
Fundamentals
Return on Equity
-74.92%
Trailing 12-Months
Asset Growth
-39.74%
Trailing 12-Months
Company Description
Invion Ltd.
Invion (IVX) is a biotechnology company focused on the research, development, and commercialization of Photodynamic Therapy (PDT) for the treatment of various cancers. Operating primarily in the healthcare and pharmaceutical sectors, Invion is dedicated to advancing its novel technologies to offer innovative treatment solutions that can improve patient outcomes. The company's core products include its proprietary PDT compounds and related systems that leverage light-activated processes to target and destroy cancer cells.
Technical Analysis
Elixinol Wellness
―
Cann Group
―
Ecofibre
―
Epsilon Healthcare Limited
―
Bod Australia Ltd
―
Options Prices
Currently, No data available
---